By Katherine Hamilton
Shares of Akoya Biosciences rose after the developer of medical imaging tools said it was considering a third party's bid instead of the previously announced buyout by Quanterix.
Akoya stock climbed 26%, to $1.34, midday Wednesday. It is still down 42% this year.
The Marlborough, Mass., company said it had received an unsolicited acquisition proposal on Tuesday offering to buy it in an all-cash deal. Under the terms of the proposed deal, each Akoya share would be exchanged for $1.40.
Earlier this year, Akoya agreed to merge with Quanterix, which offered to pay Akoya shareholders 38 cents for a share and 0.1461 shares of Quanterix common stock. Quanterix shares declined 4%, to $4.77, on Wednesday.
Akoya is reviewing and considering the new proposal. It said the deal could be considered a superior proposal, meaning it would be inconsistent with the company's fiduciary duties if Akoya didn't engage in discussions with the third party.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
May 21, 2025 14:45 ET (18:45 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。